SALE
市場調查報告書
商品編碼
1008731

冠狀病毒診斷的全球市場:各檢驗類型、用戶、所需總時間、終端用戶、地區,競爭預測和機會(2026年)

Global Coronavirus Diagnostics Market, By Type of Test, By User, By Full Test Time, By End User, By Region, Competition Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球冠狀病毒診斷市場的相關調查,市場規模和預測,佔有率,COVID-19的影響,成長要素和課題,各檢驗類型、用戶、所需總時間、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19對全球冠狀病毒診斷市場的影響

第5章 客戶的迴響

  • 品牌認知度(支援/非支援)
  • 產品的認識
  • 顧客滿意度分析
  • 價格分析
  • 未滿足需求/課題

第6章 全球冠狀病毒診斷市場預測

  • 市場規模與預測
    • 銷售額、各交易量
  • 市場佔有率與預測
    • 各檢驗類型(分子,血清)
    • 各用戶(複數,單一)
    • 各所需總時間(1∼12小時,不滿60分,13∼24小時,1日以上)
    • 各終端用戶(醫院,公共衛生研究所,民間或商業研究所,醫生研究所,其他)
    • 各企業(2020)
    • 各地區
  • 產品市場地圖

第7章 歐洲的冠狀病毒診斷市場預測

  • 市場規模與預測
    • 銷售額、各交易量
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各所需總時間
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 英國
    • 俄羅斯
    • 法國
    • 義大利
    • 德國
    • 西班牙

第8章 亞太地區的冠狀病毒診斷市場預測

  • 市場規模與預測
    • 銷售額、各交易量
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各所需總時間
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 印度
    • 中國
    • 澳洲
    • 日本
    • 新加坡
    • 韓國
    • 泰國

第9章 北美冠狀病毒診斷市場預測

  • 市場規模與預測
    • 銷售額、各交易量
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各所需總時間
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國
    • 加拿大
    • 墨西哥

第10章 中東及非洲的冠狀病毒診斷市場預測

  • 市場規模與預測
    • 銷售額、各交易量
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各所需總時間
    • 各終端用戶
    • 各國
  • 中東和非洲:各國分析
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 伊朗日冕
    • 南非
    • 科威特

第11章 南美的冠狀病毒診斷市場預測

  • 市場規模與預測
    • 銷售額、各交易量
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各所需總時間
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第12章 市場動態

  • 成長要素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • Abbott Laboratories
  • Altona Diagnostics GmbH
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F.Hoffmann-La Roche Ltd
  • GSK Biologicals SA
  • Mylab Discovery Solutions Pvt. Ltd.
  • Seegene Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics Inc.
  • Hologic, Inc.
  • Quidel Corporation

第15章 策略性建議

第16章 關於本公司&免責聲明

目錄

Global coronavirus diagnostics market was valued at USD73538.02 million in 2020 and is expected to reach USD15579.56 million by 2026.The global coronavirus diagnostics market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

The ongoing coronavirus disease is caused due to SARS-COV-2 virus and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. First case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 20th May 2021, the total number of coronavirus cases crossed 165 million, globally, of which around 144 million had recovered and over 3 million people had died.

Europe and Asia-Pacific are expected to dominate the market during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions. Major players operating in the coronavirus diagnostics market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd., Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., PerkinElmer, Inc., Quest Diagnostics Inc., Hologic, Inc., Quidel Corporation, and others.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the global coronavirus diagnostics market from 2016 to 2020.
  • To estimate and forecast the market size of the global coronavirus diagnostics market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global coronavirus diagnostics market based on type of test, user, full test time, end user, company and regional distribution.
  • To identify dominant regions and segments in the global coronavirus diagnostics market.
  • To identify drivers and challenges for global coronavirus diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus diagnostics market.
  • To identify and analyze the profile of leading players operating in global coronavirus diagnostics market.
  • To identify key sustainable strategies adopted by market players in global coronavirus diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of diagnostic players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the market players which could not be identified due to the limitations of secondary research.

TechSci Research calculated the market size of global coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to coronavirus diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders, besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global coronavirus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Coronavirus Diagnostics Market, By Type of Test:

Molecular

Serology

  • Global Coronavirus Diagnostics Market, By User:

Multiple

Single

  • Global Coronavirus Diagnostics Market, By Full Test Time:

1 Hour - 12 Hours

Less Than 60 Minutes

13 Hours - 24 Hours

More Than 1 Day

  • Global Coronavirus Diagnostics Market, By End User:

Hospitals

Public Health Labs

Private or Commercial Labs

Physician Labs

Others

  • Global Coronavirus Diagnostics Market, By Region:

Europe

  • United Kingdom
  • Russia
  • France
  • Italy
  • Germany
  • Spain

Asia-Pacific

  • India
  • China
  • Australia
  • Japan
  • Singapore
  • South Korea
  • Thailand

North America

  • United States
  • Canada
  • Mexico

Middle East & Africa

  • UAE
  • Saudi Arabia
  • Iran
  • South Africa
  • Kuwait

South America

  • Brazil
  • Colombia
  • Argentina

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Coronavirus Diagnostics Market

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Product Awareness
  • 5.3. Customer Satisfaction Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs/Challenges

6. Global Coronavirus Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Test (Molecular v/s Serology)
    • 6.2.2. By User (Multiple v/s Single)
    • 6.2.3. By Full Test Time (1 Hours to 12 Hours, Less Than 60 Minutes, 13 Hours-24 Hours, More Than 1 Days)
    • 6.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
    • 6.2.5. By Company (2020)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. Europe Coronavirus Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Test
    • 7.2.2. By User
    • 7.2.3. By Full Test Time
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. United Kingdom Coronavirus Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Test
        • 7.3.1.2.2. By User
        • 7.3.1.2.3. By Full Test Time
        • 7.3.1.2.4. By End User
    • 7.3.2. Russia Coronavirus Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Test
        • 7.3.2.2.2. By User
        • 7.3.2.2.3. By Full Test Time
        • 7.3.2.2.4. By End User
    • 7.3.3. France Coronavirus Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Test
        • 7.3.3.2.2. By User
        • 7.3.3.2.3. By Full Test Time
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Coronavirus Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Test
        • 7.3.4.2.2. By User
        • 7.3.4.2.3. By Full Test Time
        • 7.3.4.2.4. By End User
    • 7.3.5. Germany Coronavirus Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Test
        • 7.3.5.2.2. By User
        • 7.3.5.2.3. By Full Test Time
        • 7.3.5.2.4. By End User
    • 7.3.6. Spain Coronavirus Diagnostics Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value & Volume
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Type of Test
        • 7.3.6.2.2. By User
        • 7.3.6.2.3. By Full Test Time
        • 7.3.6.2.4. By End User

8. Asia-Pacific Coronavirus Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Test
    • 8.2.2. By User
    • 8.2.3. By End User
    • 8.2.4. By Full Test Time
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. India Coronavirus Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Test
        • 8.3.1.2.2. By User
        • 8.3.1.2.3. By Full Test Time
        • 8.3.1.2.4. By End User
    • 8.3.2. China Coronavirus Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Test
        • 8.3.2.2.2. By User
        • 8.3.2.2.3. By Full Test Time
        • 8.3.2.2.4. By End User
    • 8.3.3. Australia Coronavirus Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Test
        • 8.3.3.2.2. By User
        • 8.3.3.2.3. By Full Test Time
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Coronavirus Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Test
        • 8.3.4.2.2. By User
        • 8.3.4.2.3. By Full Test Time
        • 8.3.4.2.4. By End User
    • 8.3.5. Singapore Coronavirus Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Test
        • 8.3.5.2.2. By User
        • 8.3.5.2.3. By Full Test Time
        • 8.3.5.2.4. By End User
    • 8.3.6. South Korea Coronavirus Diagnostics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value & Volume
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type of Test
        • 8.3.6.2.2. By User
        • 8.3.6.2.3. By Full Test Time
        • 8.3.6.2.4. By End User
    • 8.3.7. Thailand Coronavirus Diagnostics Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value & Volume
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Type of Test
        • 8.3.7.2.2. By User
        • 8.3.7.2.3. By Full Test Time
        • 8.3.7.2.4. By End User

9. North America Coronavirus Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Test
    • 9.2.2. By User
    • 9.2.3. By Full Test Time
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Coronavirus Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Test
        • 9.3.1.2.2. By User
        • 9.3.1.2.3. By Full Test Time
        • 9.3.1.2.4. By End User
    • 9.3.2. Canada Coronavirus Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Test
        • 9.3.2.2.2. By User
        • 9.3.2.2.3. By Full Test Time
        • 9.3.2.2.4. By End User
    • 9.3.3. Mexico Coronavirus Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Test
        • 9.3.3.2.2. By User
        • 9.3.3.2.3. By Full Test Time
        • 9.3.3.2.4. By End User

10. Middle East & Africa Coronavirus Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Test
    • 10.2.2. By User
    • 10.2.3. By Full Test Time
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. Middle East & Africa: Country Analysis
    • 10.3.1. UAE Coronavirus Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Test
        • 10.3.1.2.2. By User
        • 10.3.1.2.3. By Full Test Time
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Coronavirus Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Test
        • 10.3.2.2.2. By User
        • 10.3.2.2.3. By Full Test Time
        • 10.3.2.2.4. By End User
    • 10.3.3. Iran Coronavirus Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Test
        • 10.3.3.2.2. By User
        • 10.3.3.2.3. By Full Test Time
        • 10.3.3.2.4. By End User
    • 10.3.4. South Africa Coronavirus Diagnostics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value & Volume
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type of Test
        • 10.3.4.2.2. By User
        • 10.3.4.2.3. By Full Test Time
        • 10.3.4.2.4. By End User
    • 10.3.5. Kuwait Coronavirus Diagnostics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value & Volume
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Type of Test
        • 10.3.5.2.2. By User
        • 10.3.5.2.3. By Full Test Time
        • 10.3.5.2.4. By End User

11. South America Coronavirus Diagnostics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type of Test
    • 11.2.2. By User
    • 11.2.3. By Full Test Time
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Coronavirus Diagnostics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value & Volume
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type of Test
        • 11.3.1.2.2. By User
        • 11.3.1.2.3. By Full Test Time
        • 11.3.1.2.4. By End User
    • 11.3.2. Colombia Coronavirus Diagnostics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value & Volume
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type of Test
        • 11.3.2.2.2. By User
        • 11.3.2.2.3. By Full Test Time
        • 11.3.2.2.4. By End User
    • 11.3.3. Argentina Coronavirus Diagnostics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value & Volume
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type of Test
        • 11.3.3.2.2. By User
        • 11.3.3.2.3. By Full Test Time
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Abbott Laboratories
  • 14.2. Altona Diagnostics GmbH
  • 14.3. BioMerieux SA
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Danaher Corporation
  • 14.6. F.Hoffmann-La Roche Ltd
  • 14.7. GSK Biologicals SA
  • 14.8. Mylab Discovery Solutions Pvt. Ltd.
  • 14.9. Seegene Inc.
  • 14.10. Siemens AG
  • 14.11. Thermo Fisher Scientific Inc.
  • 14.12. PerkinElmer, Inc.
  • 14.13. Quest Diagnostics Inc.
  • 14.14. Hologic, Inc.
  • 14.15. Quidel Corporation

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 3: Global Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 4: Global Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 5: Global Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 6: Global Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 7: Global Coronavirus Diagnostics Market, Product Market Map, By Company, By Value (USD Million), 2016-2026F
  • Figure 8: Global Coronavirus Diagnostics Market, Product Market Map, By Region, By Value (USD Million), 2016-2026F
  • Figure 9: Europe Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 10: Europe Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 11: Europe Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 12: Europe Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 13: Europe Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 14: Europe Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 15: Europe Coronavirus Diagnostics Market, By Country, 2016-2026F
  • Figure 16: United Kingdom Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 17: United Kingdom Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 18: United Kingdom Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 19: United Kingdom Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 20: United Kingdom Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 21: United Kingdom Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 22: Russia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 23: Russia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 24: Russia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 25: Russia Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 26: Russia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 27: Russia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 28: France Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 29: France Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 30: France Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 31: France Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 32: France Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 33: France Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 34: Italy Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 35: Italy Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 36: Italy Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 37: Italy Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 38: Italy Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 39: Italy Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 40: Germany Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 41: Germany Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 42: Germany Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 43: Germany Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 44: Germany Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 45: Germany Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 46: Spain Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 47: Spain Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 48: Spain Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 49: Spain Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 50: Spain Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 51: Spain Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 52: Asia-Pacific Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 53: Asia-Pacific Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 54: Asia-Pacific Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 55: Asia-Pacific Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 56: Asia-Pacific Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 57: Asia-Pacific Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 58: Asia-Pacific Coronavirus Diagnostics Market, By Country, 2016-2026F
  • Figure 59: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 60: India Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 61: India Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 62: India Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 63: India Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 64: India Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 65: China Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 66: China Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 67: China Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 68: China Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 69: China Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 70: China Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 71: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 72: Australia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 73: Australia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 74: Australia Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 75: Australia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 76: Australia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 77: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 78: Japan Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 79: Japan Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 80: Japan Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 81: Japan Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 82: Japan Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 83: Singapore Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 84: Singapore Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 85: Singapore Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 86: Singapore Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 87: Singapore Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 88: Singapore Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 89: South Korea Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 90: South Korea Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 91: South Korea Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 92: South Korea Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 93: South Korea Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 94: South Korea Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 95: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 96: Thailand Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 97: Thailand Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 98: Thailand Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 99: Thailand Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 100: Thailand Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 101: North America Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 102: North America Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 103: North America Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 104: North America Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 105: North America Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 106: North America Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 107: North America Coronavirus Diagnostics Market, By Country, 2016-2026F
  • Figure 108: United States Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 109: United States Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 110: United States Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 111: United States Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 112: United States Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 113: United States Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 114: Canada Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 115: Canada Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 116: Canada Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 117: Canada Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 118: Canada Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 119: Canada Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 120: Mexico Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 121: Mexico Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 122: Mexico Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 123: Mexico Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 124: Mexico Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 125: Mexico Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 126: Middle East & Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 127: Middle East & Africa Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 128: Middle East & Africa Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 129: Middle East & Africa Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 130: Middle East & Africa Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 131: Middle East & Africa Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 132: Middle East & Africa Coronavirus Diagnostics Market, By Country, 2016-2026F
  • Figure 133: UAE Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 134: UAE Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 135: UAE Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 136: UAE Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 137: UAE Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 138: UAE Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 139: Saudi Arabia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 140: Saudi Arabia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 141: Saudi Arabia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 142: Saudi Arabia Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 143: Saudi Arabia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 144: Saudi Arabia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 145: Iran Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 146: Iran Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 147: Iran Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 148: Iran Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 149: Iran Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 150: Iran Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 151: South Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 152: South Africa Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 153: South Africa Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 154: South Africa Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 155: South Africa Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 156: South Africa Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 157: Kuwait Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 158: Kuwait Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 159: Kuwait Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 160: Kuwait Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 161: Kuwait Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 162: Kuwait Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 163: South America Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 164: South America Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 165: South America Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 166: South America Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 167: South America Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 168: South America Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 169: South America Coronavirus Diagnostics Market, By Country, 2016-2026F
  • Figure 170: Brazil Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 171: Brazil Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 172: Brazil Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 173: Brazil Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 174: Brazil Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 175: Brazil Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 176: Colombia Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 177: Colombia Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 178: Colombia Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 179: Colombia Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 180: Colombia Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 181: Colombia Coronavirus Diagnostics Market Share, By End User, 2016-2026F
  • Figure 182: Argentina Coronavirus Diagnostics Market Size, By Value (USD Million), 2016-2026F
  • Figure 183: Argentina Coronavirus Diagnostics Market Size, By Volume (Million Tests), 2016-2026F
  • Figure 184: Argentina Coronavirus Diagnostics Market Share, By Type of Test, 2016-2026F
  • Figure 185: Argentina Coronavirus Diagnostics Market Share, By User, 2016-2026F
  • Figure 186: Argentina Coronavirus Diagnostics Market Share, By Full Test Time, 2016-2026F
  • Figure 187: Argentina Coronavirus Diagnostics Market Share, By End User, 2016-2026F